{"status": "Ok", "redirect_url": "https://www.merck.com/news/fda-grants-breakthrough-therapy-designation-for-calderasib-mk-1084-an-investigational-kras-g12c-inhibitor-for-certain-patients-with-newly-diagnosed-metastatic-kras-g12c-mutant-non-small-cell-lung/", "message": "News view counter 766574 successfully enlarged"}